Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms

The risk of acute myocarditis associated with COVID-19 mRNA vaccination has garnered intense (social) media attention. However, myocarditis after COVID-19 mRNA vaccination is rare and usually resolves within days or weeks. Moreover, the risks of hospitalization and death associated with COVID-19 are...

Descripción completa

Detalles Bibliográficos
Autores principales: Heymans, Stephane, Cooper, Leslie T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656440/
https://www.ncbi.nlm.nih.gov/pubmed/34887571
http://dx.doi.org/10.1038/s41569-021-00662-w
Descripción
Sumario:The risk of acute myocarditis associated with COVID-19 mRNA vaccination has garnered intense (social) media attention. However, myocarditis after COVID-19 mRNA vaccination is rare and usually resolves within days or weeks. Moreover, the risks of hospitalization and death associated with COVID-19 are greater than the risk associated with COVID-19 vaccination. Therefore, COVID-19 vaccination should be recommended in adolescents and adults.

Ejemplares similares